Search

everythinglearnresearchcommunity

for

Search:↓

The study concluded that AAI and DAA are forms of the same disease, with different symptoms in men and women, and that corticosteroid treatment is effective.

The research confirms that Hidradenitis Suppurativa is characterized by increased inflammation, disrupted skin cell organization, and abnormal metabolic processes.

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

Pertussis toxin may contribute to hair loss in alopecia areata.

Folliculotropic Mycosis Fungoides requires stage-based treatment, with early stages using skin therapies and advanced stages needing aggressive treatments.

Mesenchymal Stem Cell therapy shows promise for treating hair loss in Alopecia Areata.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

A patient with Sézary syndrome showed improvement after treatment and the study suggested follicular mucinosis might indicate future lymphoma risk.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

Macrophages are vital for skin healing, hair growth, salt balance, and cancer defense.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

A woman's long-term scalp issues were diagnosed as a rare skin disorder called cutaneous Langerhans cell histiocytosis.

Reflectance confocal microscopy helped tell periorificial dermatitis apart from similar skin conditions.

A chemical called 5-Bromo-2′-deoxyuridine caused rapid hair loss in mice by killing certain skin cells through a specific cell death pathway.

Maneb causes delayed hair follicle damage in rats.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.

Trichoscopy helps distinguish between scalp Discoid Lupus Erythematosus and Lichen Planopilaris for accurate diagnosis and treatment.

A man's skin condition and poor diet led to a scurvy diagnosis.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

UV light helped human hair transplants survive in mice without broad immunosuppression.

The patient responded well to treatment with no disease progression.

Natural killer and CD8+ T cells play a key role in hair loss in androgenetic alopecia.

The main difference in hair loss for lupus patients is smaller and fewer sebaceous glands.

Chemotherapy successfully treated both Hodgkin's disease and skin lesions.

A rare skin condition causing scarring was successfully treated with topical erythromycin and benzoyl peroxide.